Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06499883 · ClinicalTrials.gov registry record · NA
Agile Development of Innovative, Interactive Hazard Recognition and Mitigation Tools/Learning E-platforms for Workers Involved in Disaster Rescue and Recovery
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Not yet
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT06499883: Clinical Trial NA study, sponsored by The University of Texas Health Science Center, Houston.
NCT06499883 is a NA study that has not yet begun recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 64 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06499883, a NA study, has not yet begun recruiting, sponsored by The University of Texas Health Science Center, Houston.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The goal of this study is to assess Pocket Ark (PA), which is a mobile e-learning and assessment platform for use by flood remediation workers in the field. The purpose of the mobile application is to provide workers with real-time data to assist with making safe decisions during the planning phase in the flooded zone and provide a communications platform to improve logistics between operational bases and workers during and after the deployment to the flooded zone. Pocket Ark incorporates an action planner, scenario-based PPE training content, assessments (both knowledge and health-risk), personal security protection, and resource location features for workers involved in disaster rescue and recovery. Individual construction worker's readiness to be safely deployed to flooded and post-flood environments will be assessed.
Interventions
- BEHAVIORAL Pocket Ark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2024-07-11 |
| Est. Completion | 2024-07-12 |
| Phase | NA |
What is known before NCT06499883 opens enrollment
NCT06499883 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Pocket Ark is the first listed.
NCT06499883 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06499883 about?
NCT06499883 is a clinical study titled "Agile Development of Innovative, Interactive Hazard Recognition and Mitigation Tools/Learning E-platforms for Workers Involved in Disaster Rescue and Recovery". The goal of this study is to assess Pocket Ark (PA), which is a mobile e-learning and assessment platform for use by flood remediation workers in the field. The purpose of the mobile application is to provide workers with real-time data to assist with making safe decisions during the planning phase ...
What is the current status of trial NCT06499883?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2024-07-11. Estimated completion is 2024-07-12.
What interventions are being tested in trial NCT06499883?
The interventions under investigation include: Pocket Ark (BEHAVIORAL).
Who is sponsoring clinical trial NCT06499883?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06499883's enrollment target sits among peer trials
64 1147th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI